CYP17A1 and prostate carcinoma: Furthermore, several genetic association studies suggest that CYP17A1 plays an important role in different pathological conditions, such as visceral and subcutaneous fat accumulation (13), CAD (14), hypertension (12), prostate cancer (15), insulin resistance, and polycystic ovary syndrome (16).